Teza Capital Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Teza Capital Management's WST Position: Q1 2024 in Review
Teza Capital Management sold out of West Pharmaceutical (WST) in Q1 2024, closing a stake of 1,253 shares — an estimated $441K sold.
Teza Capital Management first reported a position in WST in Q4 2021 and held it in 3 quarters. The position peaked at $470K in Q4 2021. 778 funds tracked by Wall St. Rank hold WST as of Q1 2024.
- Teza Capital Management reported no remaining West Pharmaceutical position as of Q1 2024 after selling out during the quarter.
- Teza Capital Management sold 1,253 West Pharmaceutical shares in Q1 2024, an estimated $441K.
- Teza Capital Management first reported a position in West Pharmaceutical in Q4 2021 and held it in 3 quarters.
- Teza Capital Management's West Pharmaceutical position peaked at $470K in Q4 2021.
- 778 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2024.
Based on Teza Capital Management's 13F filing for Q1 2024, filed 15 May 2024.